Authors


Donald S. Wood, PhD

Latest:

The Expectations for the 2023 MDA Conference: Donald S. Wood, PhD; Sharon Hesterlee, PhD

The president and CEO, as well as the executive vice president and chief research officer, of MDA, together offered an in-depth overview of what to expect from the 2023 MDA Conference, which will be held from March 19-22, 2023, in Dallas, Texas. [WATCH TIME: 12 minutes]


Yanhong Shi, PhD

Latest:

Potential for Alzheimer Drug Development With Miniature Brain Models: Yanhong Shi, PhD

The director of stem cell biology research at City of Hope spoke on the newly developed brain organoid, which has the potential to help investigators identify pathological mechanisms of Alzheimer disease.


Kelly Papesh, DNP, APRN, FNP-BC

Latest:

The Importance of Open Communication in Patient Care: Kelly Papesh, DNP, APRN, FNP-BC

The executive director of the Association of Movement Disorder Advanced Practice Providers discussed how effective patient care in movement disorders can lead to better management and treatment outcomes. [WATCH TIME: 4 minutes]


Heather Snyder, PhD

Latest:

Pathing the Next Steps in Alzheimer Disease Research: Heather Snyder, PhD

The vice president of medical and scientific relations at the Alzheimer’s Association discussed where the organization’s efforts are currently invested and the ways to continue momentum in the Alzheimer disease field. [WATCH TIME: 5 minutes]


Adriana Banzzatto Ortega, MD

Latest:

Key Considerations in Treatment of Spinal Muscular Atrophy / Considerações essenciais para o tratamento da atrofia muscular espinhal

The expert panel shares clinical pearls for treatment and management of Spinal Muscular Atrophy. O painel de especialistas compartilha recomendações valiosas para o tratamento e manejo da atrofia muscular espinhal.


Ravindra Ganesh, MD, MBBS, FACP, Dip ABOM

Latest:

What We Know But Still Have to Learn About Long COVID

Despite advances in understanding and treating Long COVID, many questions about its mechanisms, susceptibility, and varied recovery patterns remain unresolved, underscoring the need for continued research.


Thomas H. Brannagan III, MD

Latest:

Future Treatment of hATTR Amyloidosis

Analysis of current and newer therapies for the treatment of hereditary ATTR amyloidosis.


Neelam Goyal, MD

Latest:

Clinical Pearls for Management of Generalized Myasthenia Gravis

Panelists discuss how a multidisciplinary approach involving various specialists is crucial in managing generalized myasthenia gravis (gMG), offering final insights and recommendations for health care professionals treating gMG patients.


Dileep Yavagal, MD

Latest:

The Partnership Between MT2020+ and Medtronic: Dileep Yavagal, MD, and Dan Volz

The professor of clinical neurology at University of Miami and MT2020+ chair, and president of Medtronic's Neurovascular Business discussed the effort to improve global accessibility of mechanical thrombectomy.


Wayne Feng, MD, FAHA

Latest:

Expanding the Capabilities of Treating Neuromuscular Poststroke Symptoms: Wayne Feng, MD, FAHA

The division chief of stroke and vascular neurology at Duke Health provided perspective on the multidisciplinary team needed to treat neuromuscular poststroke symptoms, as well as exciting innovations on the horizon. [WATCH TIME: 4 minutes]


Yujie Wang, MD

Latest:

Rare Reactions With Natalizumab Infusion: Yujie Wang, MD

The neurologist from the University of Washington Medical Center discussed the findings of her recent study presented at ACTRIMS Forum 2021.


Nicholas Schiff, MD

Latest:

Exploring Cognitive Motor Dissociation in Consciousness Disorders: Nicholas Schiff, MD

The Jerold B. Katz professor of neurology and neuroscience at Weill Cornell Medicine talked about a recent study that revealed patients who appeared unresponsive to verbal commands in vegetative or minimally conscious states retained high cognitive function. [WATCH TIME: 6 minutes]


Lawrence Severt, MD, PhD

Latest:

Regulatory Outlook for Atogepant in Migraine: Lawrence Severt, MD, PhD

The director at AbbVie discussed the timeline for when a regulatory decision may come for migraine treatment atogepant, and whether additional trials are necessary.


Arathi Nandyala, MD

Latest:

New Treatments in Migraine: An In-Depth Review

Although new treatments and innovations are a sign of growth in migraine care, it is important to realize that growth comes with a certain amount of pain. In clinical practice, choosing the right treatment option for patients in a time-limited visit is often a dilemma.


Jacob Zwerling

Latest:

Caregiving Youth: A Call to Action for Improved Support

A systematic approach to understanding the needs of the caregiving youth—a growing and less-studied population of caregivers—is needed to better tailor interventions, provide support, and improve care to patients and their families.


Aliza Ben-Zacharia, PhD, DNP, RN, ANP-BC, FAAN

Latest:

Optimizing Localization in Multiple Sclerosis Diagnosis: Aliza Ben-Zacharia, PhD, DNP, ANP-BC, FAAN

The assistant professor at Hunter College talked about the approach of localization to prevent misdiagnoses of multiple sclerosis and ensure patients receive appropriate treatment. [WATCH TIME: 3 minutes]


Ammar Al-Chalabi, MB, ChB, PhD

Latest:

Ongoing Clinical Trials and the Future of ALS

Key opinion leaders review the study design and mechanisms of action for drugs in ongoing clinical trials and consider the future of amyotrophic lateral sclerosis (ALS).


Gregory W. Albers, MD

Latest:

Safely Expanding the Time Window of Thrombolysis: Gregory W. Albers, MD

The professor of neurology and director of the Stanford Stroke Center discussed the ways stroke care is evolving and the significance of the TIMELESS trial, which demonstrated the safety of tenecteplase in later-window poststroke patients. [WATCH TIME: 7 minutes]


Sarah Zwerling

Latest:

Applying the Innovation Biodesign Framework to Promote Equity and Green Activity in Dementia Care

Lassell et al present a use case demonstrating the process of moving an unmet need to the “solution space” of the Innovation Biodesign Framework for addressing a healthcare challenge in a specific at-risk population: Alzheimer disease and AD-related dementias.


Laura Piccio, MD, PhD

Latest:

Sustainability and Future of Intermittent Calorie Restriction in Multiple Sclerosis: Laura Piccio, MD, PhD

The neurologist and physician scientist at Washington University in St. Louis provided perspective on the need for additional studies assessing the long-term effects of dieting strategies in multiple sclerosis. [WATCH TIME: 3 minutes]


Michael Dwyer, PhD

Latest:

AI in Multiple Sclerosis: Expert Insights Into Limitations and Opportunities

Experts share insights on the latest innovations in multiple sclerosis research, in highlights from a recent State of the Science SummitTM, presented by Neurology Live®.


Anuja Bandyopadhyay, MD

Latest:

The Potential and Limitations of AI Algorithms in Sleep Care: Anuja Bandyopadhyay, MD

The assistant professor of clinical pediatrics at Indiana University School of Medicine, and the chair of the AASM’s Artificial Intelligence in Sleep Medicine Committee, spoke about the ability of AI algorithms as tools in clinical care. [WATCH TIME: 3 minutes]


David Huang, MD

Latest:

Treating Trigeminal Neuralgia With Stereotactic Radiosurgery via CyberKnife: David Huang, MD

The radiation oncologist at Cooperman Barnabas Medical Center talked about how trigeminal neuralgia can be effectively treated with stereotactic radiosurgery using the CyberKnife offering pain relief without the need for invasive surgery. [WATCH TIME: 6 minutes]


Daniel Ackerman, MD, FAAN

Latest:

Addressing US Preventive Services Task Force Aspirin Recommendations for Stroke

In a time when complex medical communication to the public is on display, the need to ensure patient comprehension is of utmost importance for vascular neurologists.


Soeren Mattke, MD, DSc

Latest:

Impact of Blood Tests on Wait Times and Treatment in Alzheimer Disease: Soeren Mattke, MD, DSc

The director of the Brain Health Observatory at the University of Southern California discussed how blood tests for Alzheimer disease could significantly reduce diagnostic wait times and improve treatment monitoring. [WATCH TIME: 4 minutes]


Afolasade Fakolade, PhD

Latest:

Lessons from a Multiple Sclerosis Feasibility Study Focused on Movement Medicine: Afolasade Fakolade, PhD

The assistant professor at Queen’s University discussed results from a pilot trial that evaluated the impact of a dyadic physical activity intervention among both caregivers and patients with multiple sclerosis. [WATCH TIME: 3 minutes]


Erica A. Schuyler, MD

Latest:

AUPN Leadership Minute Episode 37: International Physicians in Neurology

Episode 37 of the AUPN Leadership Minute features David G. Standaert, MD, PhD, of the University of Alabama at Birmingham; and Erica A. Schuyler, MD, of the University of Connecticut. [WATCH TIME: 5 minutes]


Joanna Fong-Isariyawongse, MD, FAAN, FAES

Latest:

A Provider's Cheat Sheet Guide to Understanding Sleep

Sleep is critical for physical and mental health, with its insufficiency leading to various disorders and increased health risks; thus, clinicians should integrate sleep assessments and hygiene strategies into their clinical care.


Patricia Bobryk, MHS, MSCS, PT, ATP

Latest:

Physical Therapy Approach for Fatigue Management in Multiple Sclerosis

Fatigue, although not immediately visible, is among the most debilitating symptoms of multiple sclerosis, affecting not only patients' day-to-day functioning but their quality of life.


Stephan Züchner, MD, PhD

Latest:

The Potential of Genetic Therapies in Neuromuscular Diseases: Stephan Züchner, MD, PhD

At the 2023 MDA conference, the professor for human genetics and neurology at the University of Miami Miller School of Medicine talked about the role of genetics in neuromuscular diseases and potential therapies. [WATCH TIME: 5 minutes]

© 2024 MJH Life Sciences

All rights reserved.